Clinical Trial Search

Primary: Geometric Mean Titers (GMTs) of Hemagglutination Inhibition (HI) Antibodies Before and After Fluzone® Vaccination — 5.36; 15.1; 169; 135 Titer

Primary: Mean Change From Baseline in the Nighttime Symptom Score (NSS) — -2.3; -3.1; -2.2 Score on a Scale — p=<0.001

Primary: Duration of Hyperglycaemia (>126 mg/dL) in Hours at Baseline Compared to After 12 Weeks on Treatment — 17.31; 17.53; 15.30; 10.83 Hours — p=0.064

Primary: Visual Analogue Scale (VAS) Pain Score — 2.5; 4.4 points on a scale — p=.003

Primary: International Index of Erectile Function (IIEF), Erectile Function (EF) Domain Score- Change From Baseline to Week 6 Last Observation Carried Forward (LOCF) — 10.96…

Primary: Dermal Reactions — 46; 97; 151; 6 Participants

Primary: Change in Mean Sitting Systolic Blood Pressure (MSSBP) — 159.7; 159.0; 131.2; 137.5 mm Hg

Primary: Number of Patients With ST-segment Elevation Resolution Equal or More Than 50% — 47; 51 participants — p=0.56

Primary: Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8) — 80.27; 62.15 scores on a scale — p=<0.0001

Primary: The Number of Women Who Received Systemic Narcotic Analgesics in the First 24 Hours Postpartum — 8; 37 participants — p=0.05

Primary: Participants´Endpoint Change From Baseline in Hamilton Anxiety Rating Scale — 22.59; 22.73 Units on a scale — p=<0.001

Primary: Intra-operative Blood Loss During Vaginal Hysterectomy

Primary: Number of Participants Who Experienced an Adverse Event — 472 participants

Primary: Participants With 1 or More Serious Vaccine-Related Adverse Experiences — 0; 1 participants

Primary: Change From Baseline for Daytime Asthma Symptom Score — 0.32; 0.16; 0.29; 0.13 Units on scale — p=0.015